$.10 $.05 $.14 $.01
Diluted $.10 $.05 $.14 $.01
Shares used in computing
earnings per share:
Basic 17,771,799 17,466,368 17,744,656 17,442,969
Diluted 17,919,695 18,009,774 17,904,128 17,912,380
CONSOLIDATED SEGMENT REVENUE DETAIL
(dollars in thousands)
Three Months Six Month
Ended June 30, Ended June 30,
2008 2007 2008 2007
DBM $16,575 $16,161 $33,541 $31,643
Hybrid/Synthetic 727 408 1,371 641
Traditional Tissue 5,250 4,558 10,360 9,169
Spinal Allografts 2,286 3,221 4,536 6,009
Client Services 2,397 1,944 4,821 3,872
Other Product Lines 318 178 555 353
Revenue $27,553 $26,470 $55,184 $51,687
OSTEOTECH, INC. and Subsidiaries
CONDENSED CONSOLIDATED BALANCE SHEET
(dollars in thousands)
June 30, December 31,
2008 2007
Assets
Cash and cash equivalents $19,128 $22,777
Accounts receivable, net 23,177 19,353
Deferred processing costs 29,985 30,850
Inventories 1,314 1,171
Prepaid expenses and other current assets 3,971 3,957
Total cur
'/>"/>
SOURCE Osteotech, Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 Related medicine news :1.
Osteotech to Present at First Albany Capitals Regenerative Technologies Conference in New York2.
Osteotech Completes Tissue Supply Agreement With LifeNet Health3.
Osteotech Announces Third Quarter Earnings Release and Conference Call Schedule4.
Osteotech Reports 2007 Third Quarter Financial Results; Core Segment Revenue Increased 28%; Gross Margin Improved to 55%; Diluted Earnings Per Share of $.095.
Osteotech Signs Agreement To Distribute Harvest Technologies BMAC(TM) System6.
Osteotech Engages BioHorizons as Exclusive Distributor to International Dental Market7.
Osteotech Announces the Unexpected Passing of Audit Committee Member Leads to Receipt of Nasdaq Deficiency Letter8.
New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites9.
Haemacure Reports Third Quarter 2007 Results10.
First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion11.
Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best